Insurance Manufacturing Patients Provider 
Physician's Weekly
JUNE 18, 2025
Cost-sharing interventions and patient education can help improve access to GLP-1 receptor agonists for patients with obesity, according to an abstract presented at the AACE Annual Meeting 2025. The patient was enrolled in a cost-sharing program that reduced her out-of-pocket expenses by 70%, allowing her to access the medication.
Plum Health
AUGUST 30, 2024
Read on to see how you can navigate insurance or skip the headache entirely by joining with a Direct Primary Care membership to Plum Health. Depending on your insurance plan, you might run into issues like formulary exclusions (where your plan doesn't cover Ozempic at all) or high copayments that make it difficult to afford.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Medical Futurist
JUNE 21, 2025
To diagnose and treat a patient, a healthcare professional listens to the patient, reads their health files, looks at medical images and interprets laboratory results. ” Patient points to lower abdomen. M-LLM (Translating for Specialist): “The patient is pointing to the lower abdomen.”
FDA Law Blog
MAY 31, 2021
PhRMA Sues CMS Challenging MDRP Rule Curbing Patient Assistance. Manufacturers provide patient savings programs at the pharmacy counter to defray the patient’s out-of-pocket costs such as co-pays and deductibles. In December 2020, CMS published a final rule making several changes to the MDRP regulations.
FDA Law Blog
OCTOBER 9, 2023
The ACA sets an annual cap on the amount that insurers can require insured individuals to pay out of pocket for their medical expenses. Once an individual reaches this annual cap, the insurer is solely responsible for covering the individual’s remaining medical expenses that year.
Physician's Practice
JUNE 9, 2025
Don't miss our previous episodes on immigration policy and the physician shortage , AI diagnostic tools , patient autonomy and malpractice law. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. 68: Hidden risks of prescribing GLP-1 drugs with Ericka L. Adler, J.D.,
FDA Law Blog
AUGUST 7, 2023
Through ELP, CDRH staff visit sites that provide formal training and enhance understanding on topics such as how products are developed and how they fit into the larger healthcare system. The visits are intended purely to provide a training perspective, and not for CDRH staff to opine on any regulatory functions.
Expert insights. Personalized for you.
52 
Let's personalize your content